Lipid Nanoparticles for Driving Macrophages to Promote Proinflammatory Cytokine Upregulation
- 16 June 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 8 (25) , 12818-12827
Abstract
No abstract availableFunding Information
- National Research Council Canada (CGT-504-1)
- Canada Research Chairs
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2022-04398)
- Mitacs
This publication has 32 references indexed in Scilit:
- Design and Optimization of Selectivity-Tunable Toll-like Receptor 7/8 Agonists as Novel Antibody–Drug Conjugate PayloadsJournal of Medicinal Chemistry, 2024
- Macrophage states: there's a method in the madnessTrends in Immunology, 2023
- Macrophages in health and diseaseCell, 2022
- Nanoparticles in the clinic: An updateBioengineering & Translational Medicine, 2019
- Combining Nanomedicine and ImmunotherapyAccounts of Chemical Research, 2019
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA VaccinesMolecular Therapy Nucleic Acids, 2019
- Branched‐Tail Lipid Nanoparticles Potently Deliver mRNA In Vivo due to Enhanced Ionization at Endosomal pHSmall, 2019
- Modulation of Innate Immune Responses via Covalently Linked TLR AgonistsACS Central Science, 2015
- Insight into nanoparticle cellular uptake and intracellular targetingJournal of Controlled Release, 2014
- Analysis of the 22-NBD-cholesterol transfer between liposome membranes and its relation to the intermembrane exchange of 25-hydroxycholesterolColloids and Surfaces B: Biointerfaces, 2010